Deals
There's a Huge Investment Opportunity in Chinese Bones
This article is for subscribers only.
Shuai Yuan wants to help all the hunched-up grannies in China stand tall again.
The former banker worked on the 2010 initial public offering of a Chinese maker of hip implants as a summer associate at Morgan Stanley and went on to see that company acquired for more than double the value. Now an entrepreneur, he’s seeking to capitalize on the shortfalls of China’s public hospital system and surging demand from those seeking care for creaking knees and fractured hips.